The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, European Medical Solutions's share price is €4.72.
European Medical Solutions's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €11.80. Hence, European Medical Solutions's PS Ratio for today is 0.40.
Good Sign:
European Medical Solutions stock PS Ratio (=0.42) is close to 3-year low of 0.39.
The historical rank and industry rank for European Medical Solutions's PS Ratio or its related term are showing as below:
STU:AS00'
s PS Ratio Range Over the Past 10 Years
Min: 0.04 Med: 421.56 Max: 16440.72
Current: 0.42
During the past 13 years, European Medical Solutions's highest PS Ratio was 16440.72. The lowest was 0.04. And the median was 421.56.
STU:AS00's PS Ratio is ranked better than 97.09% of 929
companies
in the Biotechnology industry
Industry Median: 9.91
vs STU:AS00: 0.42
During the past 13 years, European Medical Solutions's highest 3-Year average Revenue per Share Growth Rate was 12.30% per year. The lowest was -72.90% per year. And the median was -30.30% per year.
Back to Basics: PS Ratio
European Medical Solutions (STU:AS00) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
European Medical Solutions PS Ratio Related Terms
European Medical Solutions PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, European Medical Solutions's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
European Medical Solutions PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, European Medical Solutions's PS Ratio distribution charts can be found below:
* The bar in red indicates where European Medical Solutions's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
European Medical Solutions's Share Price of today is €4.72.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. European Medical Solutions's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €11.80.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
European Medical Solutions (STU:AS00) has a PS Ratio of 0.40 as of Jul. 06, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on European Medical Solutions and its competitors. This is 100% below median its historical median of 421.56. Over the past decade, European Medical Solutions' PS Ratio has ranged from 0.04 to 16,440.72. According to the industry distribution chart, European Medical Solutions ranks #27 out of 929 companies in the Biotechnology industry, placing it in the top 2.9%.
Is European Medical Solutions' PS Ratio too high?
European Medical Solutions' current PS Ratio of 0.40 is 100% below median its 10-year median of 421.56. Over the past 10 years, this metric has ranged from a low of 0.04 to a high of 16,440.72. The Biotechnology industry median PS Ratio is 9.91. European Medical Solutions' value of 0.40 is 96% below this industry median. Based on the distribution chart, European Medical Solutions ranks #27 out of 929 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, European Medical Solutions has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does European Medical Solutions' PS Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, European Medical Solutions ranks #27 out of 929 companies for PS Ratio. This places European Medical Solutions in the top 3% of its industry — outperforming the majority of peers. The industry median PS Ratio is 9.91. European Medical Solutions' value of 0.40 is 96% below this benchmark. Historically, European Medical Solutions' own PS Ratio has ranged from 0.04 to 16,440.72 over the past decade. While the company's 10-year median is 421.56 vs. the industry median of 9.91, European Medical Solutions has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.91, based on 929 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. European Medical Solutions's current PS Ratio of 0.40 is 96% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on European Medical Solutions and its competitors. For the Biotechnology industry, the median PS Ratio is 9.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. European Medical Solutions's current PS Ratio is 0.40, which is 100% below median its own 10-year median of 421.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is European Medical Solutions stock overvalued right now?
European Medical Solutions (STU:AS00) has a current PS Ratio of 0.40. The stock's GF Value™ is €8.16, compared to a current price of €4.72 — trading 42.2% below its estimated fair value. The current PS Ratio is 0.40, which is 100% below median its 10-year median of 421.56 and 96% below the Biotechnology industry median of 9.91. European Medical Solutions' overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For European Medical Solutions (STU:AS00), the current PS Ratio is 0.40 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is European Medical Solutions (STU:AS00) Overvalued in 2026?
Based on GuruFocus' analysis, European Medical Solutions stock appears to be undervalued.
The current stock price of €4.72 is trading 42.2% below its estimated GF Value™ of €8.16.
Key valuation signals for STU:AS00:
PS Ratio: 0.40 (100% below median its 10-year median of 421.56)
GF Value™: €8.16 vs. price of €4.72 (42.2% below fair value)
Industry Position: 96% below the Biotechnology median (#27 of 929)
No single metric tells the full story. See the STU:AS00 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.
48GF Score
Get the complete analysis for STU:AS00
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:AS00 has been successfully added to your 
